|Total Value Locked||24H|
|in ETH||6K ETH||-10.4%|
|in BTC||187 BTC||-12.2%|
|ETH Locked||1.3K ETH||+6.3 ETH|
|% Supply Locked||< 0.01%|
Enzyme is a decentralized asset management infrastructure built on Ethereum. It serves two types of users: 1) Portfolio Managers Enzyme allows anyone to build, scale and monetize investment strategies of their choice - from discretionary and robo to ETF’s, market making, yield farming and more. Portfolio Managers can take advantage of the various building blocks offered by Enzyme including: a large array of DeFi connections (eg. lending, pools, derivatives, farming), 150+ supported assets, optional flexible fee structure, rulesets dictating who can subscribe to a given strategy and on what terms, in-built accounting tools and a suite of advanced risk management tools. 2) Subscribers to portfolios Enzyme enables users to search for and subscribe to strategies with a proven track record making the process research and portfolio management simpler while also maintaining control of your assets and having full transparency around the terms. Enzyme, formerly known as Melon Protocol, has been on main-net since Feb 2019 and v2 was launched to main-net in Jan 2021. Enzyme’s smart contracts are always fully tested and audited before any main-net deployments are made. Importantly, v2 features an upgradability approach which allows users to stay in control. Enzyme’s token is MLN and has a dual use. It is 1) used to pay fees to the network by users and 2) used to incentivize developers to build on Enzyme. It is governed by a DAO known as the Enzyme Council which is made up of technical experts and user representatives.
You can access Enzyme from the app. Portfolio Managers can build and manage their products from the Portfolio Manager dashboard. Investors can browse and manage the strategies they subscribe to from the Investor dashboard.